ABSTRACT
Hemophilia A, an X-linked disease caused by deficiency of factor VIII, is characterized by variation in clinical severity and coagulation activity. This variation is though to reflect heterogeneity of mutations in the factor VIII gene. Here we describe a CG-to-CA mutation within a potential cryptic donor splice site in intron 4 of the factor VIII gene from a patient with mild disease. This mutation makes the cryptic sequence resemble more closely the consensus sequence for donor splice sites. We infer that the mutation activates the cryptic donor splice site, which in turn causes a defect in RNA processing.
Subject(s)
Factor VIII/genetics , Genes , Hemophilia A/genetics , Introns , Mutation , RNA Splicing , Adult , Cloning, Molecular , DNA Restriction Enzymes , Humans , MaleABSTRACT
Hemophilia A is an X-linked disorder of coagulation caused by a deficiency of factor VIII. By using cloned DNA probes, we have characterized the following five different partial deletions of the factor VIII gene from a panel of 83 patients with hemophilia A: (i) a 7-kilobase (kb) deletion that eliminates exon 6; (ii) a 2.5-kb deletion that eliminates 5' sequences of exon 14; (iii) a deletion of at least 7 kb that eliminates exons 24 and 25; (iv) a deletion of at least 16 kb that eliminates exons 23-25; and (v) a 5.5-kb deletion that eliminates exon 22. The first four deletions are associated with severe hemophilia A. By contrast, the last deletion is associated with moderate disease, possibly because of in-frame splicing from moderate disease, possibly because of in-frame splicing from adjacent exons. None of those patients with partial gene deletions had circulating inhibitors to factor VIII. One deletion occurred de novo in a germ cell of the maternal grandmother, while a second deletion occurred in a germ cell of the maternal grandfather. These observations demonstrate that de novo deletions of X-linked genes can occur in either male or female gametes.
Subject(s)
Chromosome Deletion , Factor VIII/genetics , Genes , Hemophilia A/genetics , DNA Restriction Enzymes , Exons , Female , Genetic Carrier Screening , Hemophilia A/blood , Humans , Male , Pedigree , Polymorphism, GeneticABSTRACT
Haemophilia A is a common disorder of blood coagulation caused by a deficiency of factor VIII. It is inherited as an X-linked recessive trait, and one-third of all cases are thought to result from de novo mutations. The clinical severity of haemophilia A varies markedly among different families and a subset of the patients with severe disease develop antibodies against factor VIII, called inhibitors. Because of this heterogeneity, it is likely that many different molecular lesions result in haemophilia A. Indeed, of the nine mutations described to date, all appear to be unique changes. However in this study of 83 patients with haemophilia A we have identified two different point mutations, one in exon 18 and one in exon 22, that have recurred independently in unrelated families. Each mutation produces a nonsense codon by a change of CG to TG, and each occurred de novo on the X-chromosome donated by the maternal grandfather. These observations strongly support the view that CpG dinucleotides are mutation hotspots.
Subject(s)
Hemophilia A/genetics , Mutation , Base Composition , DNA/genetics , DNA/isolation & purification , Exons , Factor VIII/genetics , Female , Genes , Humans , Male , PedigreeABSTRACT
Burkitt-like lymphoma was seen in a hemophilic boy with impaired cell-mediated immunity, of the type described in healthy hemophiliacs. The coexistence of two rare diseases, hemophilia and Burkitt's lymphoma in an immunosuppressed patient is suggestive of a blood-borne agent transmitted with factor VIII concentrates which might be an immune modifier and/or oncogenic at the same time.